IPP Bureau
Mandaviya chairs high level meeting to review COVID-19 status
By IPP Bureau - June 24, 2022
The Minister directed officials to continue to focus on surveillance and on Whole Genome Sequencing to scan for any possible mutation and also directed for monitoring hospitalizations due to COVID-19 and SARI/ILI cases
Silo Pharma expands license agreement and patent portfolio
By IPP Bureau - June 24, 2022
Silo enters into commercial evaluation license agreement for next generation liposomes
Biolexis and Akston Biosciences announce encouraging results of thermostable 2nd Gen COVID-19 vaccine
By IPP Bureau - June 24, 2022
An interim analysis of this data shows no significant safety issues and a 91% seroconversion rate at Day 56.
Rivaroxaban approved in Japan for patients with PAD after revascularisation
By IPP Bureau - June 24, 2022
It´s the first trial to demonstrate the benefits of dual pathway inhibition
CPC Scientific announces new California peptide API manufacturing facility
By IPP Bureau - June 24, 2022
The 41,000 sq ft facility will be utilized to manufacture clinical to commercial-grade peptide products for increased manufacturing capacity
Merck KGaA doubles HPAPI production capacity in Wisconsin
By IPP Bureau - June 24, 2022
This new €59 million, 70,000 square foot facility, officially opened today, brings 50 new jobs to the area
Menarini Group and Radius Health submit new drug application to the USFDA for Elacestrant
By IPP Bureau - June 23, 2022
Intended for potential treatment of ER+/HER2- advanced or metastatic breast cancer patients
Glenmark Pharmaceuticals to address USFDA’s observation
By IPP Bureau - June 23, 2022
U.S. FDA has issued Form 483 with six observations after an inspection of the company’s formulation manufacturing facility based out of Baddi
Alembic Pharmaceuticals shows growth in May 2022
By IPP Bureau - June 23, 2022
Ex-Azithromycin has shown a growth of 8% and 14% in April 2022 and May 2022 respectively
Avni announces subscription model menstrual hygiene products
By IPP Bureau - June 23, 2022
The array available for a subscription includes popular products to make menstrual hygiene a regular practice and extend further affordability to its users
Piramal Pharma Solutions appoints Herve Berdou as COO
By IPP Bureau - June 23, 2022
Brings 25 years of global operations and supply chain experience to Piramal
Nippon Express launches new transport service using environmental-friendly isothermal packaging
By IPP Bureau - June 23, 2022
Becomes first Japanese logistics company to collaborate with EMBALL’ISO, which has a proven track record in vaccine transport
Indian Pharma Post organizes e-Conference on ‘Role of Digitalization in Pharma Sector’ June 24
By IPP Bureau - June 23, 2022
Sanjay Verma of Akums Drugs & Pharmaceuticals, Manu Gupta of Cadila Pharmaceuticals, Rahul Borse of RPG Life Sciences, Krishna Sai T of Biocon and Amit Saluja of NASSCOM are speakers
IOL Life Sciences incorporated as a subsidiary of IOL Chemicals and Pharmaceuticals
By IPP Bureau - June 22, 2022
The company is strategically expanding its product portfolio with a pipeline of new products that will form a strong foundation for future growth.
Merck presents positive results from phase 1/2 study evaluating V116
By IPP Bureau - June 22, 2022
V116 designed to target serotypes that account for 85% of all invasive pneumococcal disease in individuals aged 65 and over in the United States as of 2019
